MIRA INFORM REPORT

 

 

Report Date :

28.06.2007

 

IDENTIFICATION DETAILS

 

Name :

ANCALIMA LIFESCIENCES LIMITED

 

 

Formely Known As:

Pfiscar India Limited

 

 

Registered Office :

LGF-2, A-337 (Basement) Shivlik, New Delhi – 110017.

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

02.05.1988

 

 

Com. Reg. No.:

031451

 

 

CIN No.:

[Company Identification No.]

U52110DL1988PLC031451

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical and Veterinary  Formulation.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

 

 

 

 

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

 

Maximum Credit Limit :

USD24000

 

 

Status :

Small Company

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

LGF-2, A-337 (Basement) Shivlik, New Delhi – 110017, India

Tel. No.:

91-130-2484108

Mobile No.:

91-9896084700

Fax No.:

91-130-2484109

E-Mail :

admin@ancalima.com

sales@ancalima.com

exports@ancalima.com

Website :

webmaster@ancalima.com

 

 

DIRECTORS

 

Name :

Ms. Garg Sakshi

Designation :

Director

Address :

935, Sector – 14, Sonepat , Haryana.

Date of Birth/Age :

14.12.1974

Date of Appointment :

01.02.2005

 

 

Name :

Mr. Garg Rajeev

Designation :

Director

Address :

935, Sector – 14, Sonepat , Haryana.

Date of Birth/Age :

01.11.1972

Date of Appointment :

16.02.1996

 

 

Name :

Mr. Singhla Vishal

Designation :

Director

Address :

998, Sector – 14, Sonepat , Haryana.

Date of Birth/Age :

14.01.1974

Date of Appointment :

28.09.2004

 

 

Name :

Mr. Garg Ram

Designation :

Director

Address :

935, Sector – 14, Sonepat , Haryana.

Date of Birth/Age :

20.06.1943

Date of Appointment :

01.02.2004

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

No. of Shares

 

Sita Ram Garg

9511

 

Raghbir Chand Garg

501

 

Gore Lal

01

 

Sukhdev Garg

10

 

Nirmala Garg

501

 

Shanti Devi

01

 

Ashok Kumar

01

 

Atha Ram

01

 

Nirmal Goel

01

 

Minakshi Garg

01

 

Natasha Garg

01

 

Kaushalya Devi

01

 

Rajeev Garg

14277

 

The New India International Chemicals Private Limited

13300

 

Surat Singh Kumar

7001

 

Sakshi Garg

2225

 

     Total

49333

 

 

Equity Shares Breakup

Category

Percentage

Directors or relatives of Director

100.00

  Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical and Veterinary Formulation.

 

 

GENERAL INFORMATION

 

Bankers :

  • HDFC Bank. Delhi
  • HDFC Bank. Sonepat
  • Canara Bank

 

 

 

Unsecured Loan

Facilities :

Particulars

Amount in Rs. Million(as on 31.03.2006)

Car Loan from Tata Finance

0.286

Car Loan from ICICI Bank

0.029

Car Loan from Kotak Mahindra

0.773

Car Loan from HDFC

5.530

Canara Bank Bill Discount

2.757

Term Loan From Canara Bank

1.558

Total

8.933

 

Unsecured Loan

Particulars

Amount in Rs. Million(as on 31.03.2006)

Rajeev Garg

0.308

Sakshi Garg

0.008

Shareholders

3.43

Total

3.742

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Mr. Ahuja Arora and Associates

Chartered Accountant

Address :

A-37, Shivlik, New Delhi- 110017, India.

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

50000

Equity Shares

Rs. 100/- each

Rs. 5.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

49335

Equity Shares

Rs. 100/- each

Rs. 4.933 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

4.933

4.933

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

1.283

1.680

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

6.216

6.613

LOAN FUNDS

 

 

 

1] Secured Loans

 

9.018

8.933

2] Unsecured Loans

 

3.442

3.742

TOTAL BORROWING

 

12.460

12.675

DEFERRED TAX LIABILITIES

 

0.000

0.019

 

 

 

 

TOTAL

 

18.676

19.307

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

10.099

12.089

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.150

0.150

DEFERREX TAX ASSETS

 

0.156

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

7.866

7.937

 

Sundry Debtors

 

8.197

10.893

 

Cash & Bank Balances

 

0.182

0.670

 

Other Current Assets

 

0.000

0.000

 

Loans & Advances

 

2.486

2.039

Total Current Assets

 

18.731

21.539

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

9.985

14.139

 

Provisions

 

0.475

0.331

Total Current Liabilities

 

10.460

14.470

Net Current Assets

 

8.271

7.069

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

18.676

19.307

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2006

31.03.2005

Sales Turnover

 

21.357

26.553

Other Income

 

20.719

49.264

Total Income

 

42.076

75.817

 

 

 

 

Profit/(Loss) After Tax

 

(4.315)

0.735

 

 

 

 

Expenditures :

 

 

 

 

Raw Material Consumed

 

31.098

56.904

 

Purchases made for re-sale

 

0.000

0.000

 

Consumption of stores and spares parts

 

0.209

0.873

 

Increase/(Decrease) in Finished Goods

 

(0.488)

(0.693)

 

Salaries, Wages, Bonus, etc.

 

2.643

3.555

 

Managerial Remuneration

 

0.579

0.408

 

Payment to Auditors

 

0.045

0.044

 

Interest

 

0.834

0.011

 

Insurance Expenses

 

0.153

0.164

 

Power & Fuel

 

0.844

0.018

 

Depreciation & Amortization

 

1.732

1.271

 

Other Expenditure

 

8.740

12.525

Total Expenditure

 

46.391

75.081

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2006

31.03.2005

PAT / Total Income

(%)

 

(10.26)

0.97

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

(20.20)

2.77

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

(14.81)

2.18

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

(0.69)

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

3.69

4.10

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.79

1.49

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Subject is a pharmaceutical company incorporated in India. Subject is manufacturer and exporter of pharmaceutical and veterinary formulations in the form of injectables (liquid and dry injections), eye ear nasal drops, ointments and creams. Subject also exports tablets, capsules, soft gelatin capsules, herbal products from its associate companies. Subject products are available in Indian market as well as in other countries. Subject also manufacture products under third party arrangements.

 

Their Mission

To meet the customer's expectations and provide quality products to their full satisfaction which shall ensure value for money.

 

Company Profile

They are deep-rooted in the business of pharmaceutical formulations and allied products.They are an ISO 9001:2000 certified company.They, at Subject, are a team of dedicated and talented Quality Assurance Professionals, Manufacturing Chemists, Machine Operators, Engineering Professionals and Technicians continuously working to manufacture quality formulations as per the latest International Standards.  Their focus reverberates around well formulated, cost effective medicines with quality assurance. Product Range updates and the information about products manufactured & marketed by them besides conventional media like "Drug Today" are also provided on Internet for quicker and easy access by their prospective customers. This powerful blend of Pharma and IT results a significant overall efficiency improvement and reduces response time to queries raised by prospective customers not only in India but around the world.

They, at Subject are committed to understand and meet the customer’s expectations and provide quality products to their full satisfaction which shall ensure value for money.

They take pledge to serve with affordable and quality Medicines to populace at large. They will move towards Healthier tomorrow by keep on making & marketing Pharmaceutical Formulations In Strict Control And Research to deliver products of world class quality.

They are also committed to meet all legal and statutory requirements for continuous business growth, ensuring increased profitability through motivated and trained work force and by adopting the mantra of continual improvement.

 

 

 

 

Name of the company

ANCALIMA LIFESCIENCES LIMITED

Presented By

Canara Bank, Sonepat, Haryana

1) Date and description of instrument creating the change

21.01.1995 – Registered on 17.02.1995 Agreement

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 2.500 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation of stocks of Syrup, Injections, other pharmaceuticals, and packing materials and all other goods and commodities now lying or thereafter stored at the godown, yards and premises at 50th K.M. Stone, G. T. Road, Murthal, or at any other place(s) including those in transit

4) Gist of the terms and conditions and extent and operation of the charge.

The interest on Cash Credit shall be charged at the rate of 4 % over RBI rate subject to a minimum of 16% per annum, with quarterly rests.

Margin : 25% Payable on demand

5) Name and Address and description of the person entitled to the charge.

Canara Bank, Sonepat, Haryana

6) Date  and brief description of instrument modifying the charge

05.09.2005

Supplemental Agreement

Previously modification form time to time and finally modified on 18.06.2004 for change in terms and conditions for the enhanced limit of Rs. 5.000 Millions and modification registered on 16.07.2004

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

The OCC Limit stands enhanced from Rs. 5.000 Million to Rs. 6.000 Million

The rate of interest shall now be charged at the rate of 2% over ongoing PLR subject to a minimum of 12.75% per annum with monthly rests or at such other rates(s) as may be specified by the Bank from time to time.

 

Other terms and conditions remained the same.

 

This form is for

Creation of Charge

Corporate identity number of the company

U52110DL1988PLC031451

Name of the company

ANCALIMA LIFESCIENCES LIMITED

Address of the registered office or of the principal place of  business in India of the company

LGF-2, A-337 (Basement) Shivlik, New Delhi – 110017, India

Type of charge

Immovable Property, Movable Property

Particular of charge holder

Canara Bank, Sonepat, Haryana

Nature of description of the instrument creating or modifying the charge

  • Term loan of Rs. 1.365 Millions for purchase of machinery against security of machinery to be purchase and collateral security as per agreement attached and personal guarantee of Rajiv Garg, Vishal Garg and Sakshi Garg.
  • Copy of Agreement enclosed

Date of instrument Creating the charge

13.01.2007

Amount secured by the charge

Rs. 1.365 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

12.5%

 

Terms of repayment

Loan shall repay the entire loan in 60 monthly instalments, each of Rs. 0.023 Millions instalment shall commence from February 2007

 

Margin

25%

 

Extent and operation of the charge

First charge on machinery, as per attachment

Short particulars of the property charged

  • Machinery situated at factory premises 50th K.M. Stone, Highway No 1, Murthal, Sonepat

 

Fixed Assets

  • Air conditioner
  • Building
  • Building under construction
  • Car – Alto
  • Car Esteem
  • Car Honda City
  • Car Mahindra
  • Car Santro
  • Car Zen
  • CCD Camera
  • Computer
  • Dies and Tools
  • Electrical Equipement
  • EPABX
  • Fire Extinguisher
  • Furniture and Fixture
  • Generator
  • Lab Equipement
  • Land
  • Mobile Phone
  • Plant and Machinery
  • Printer and Scanner
  • Refrigerator
  • Scooter
  • Software
  • Telephone Equipment
  • Vacume Cleaner
  • Weight Machine

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.40.81

UK Pound

1

Rs.81.57

Euro

1

Rs.54.91

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

-

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

37

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions